The role of angiopoietins as potential therapeutic targets in renal cell carcinoma. - Wikidata - wikimedia - TriplyDB

The role of angiopoietins as potential therapeutic targets in renal cell carcinoma.

The role of angiopoietins as potential therapeutic targets in renal cell carcinoma.

http://www.wikidata.org/entity/Q33912405

about

Lenvatinib therapy for the treatment of patients with advanced renal cell carcinoma.Anti-S1P Antibody as a Novel Therapeutic Strategy for VEGFR TKI-Resistant Renal Cancer.Association of Angiopoietin-2 and Ki-67 Expression with Vascular Density and Sunitinib Response in Metastatic Renal Cell Carcinoma.Strategies to overcome therapeutic resistance in renal cell carcinoma.Therapeutic targeting of the angiopoietin-TIE pathway.RNA interference-mediated silencing of speckle-type POZ protein promotes apoptosis of renal cell cancer cells.Efficacy of Cotargeting Angiopoietin-2 and the VEGF Pathway in the Adjuvant Postsurgical Setting for Early Breast, Colorectal, and Renal Cancers.Angiopoietins bind thrombomodulin and inhibit its function as a thrombin cofactor.

P2860

Q30249385-307AB641-F13A-444D-AFA1-E7D167E47828 Q35568516-9ECF4F09-AE38-4783-8D57-2A91C4DF8E32 Q35995721-442EEC56-302B-4B7D-B830-1AB562E3ECBB Q39089402-54AB351E-F06D-4A04-9F25-ED202D04D7C3 Q39321127-02C489AD-180B-46ED-BDFA-8C0DBD11E884 Q40656637-BF6C76B2-40AE-47DC-B2BE-B4F0F74827E7 Q42067472-3C016B8C-CECC-4CAB-A2E6-8EC62647156F Q49967364-138B40B3-5E65-4005-B3E2-48F6CD967E41

P2860

The role of angiopoietins as potential therapeutic targets in renal cell carcinoma.

http://www.wikidata.org/entity/Q33912405

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

The role of angiopoietins as potential therapeutic targets in renal cell carcinoma.

@ast

The role of angiopoietins as potential therapeutic targets in renal cell carcinoma.

@en

type

label

The role of angiopoietins as potential therapeutic targets in renal cell carcinoma.

@ast

The role of angiopoietins as potential therapeutic targets in renal cell carcinoma.

@en

prefLabel

The role of angiopoietins as potential therapeutic targets in renal cell carcinoma.

@ast

The role of angiopoietins as potential therapeutic targets in renal cell carcinoma.

@en

P1433

Q33912405-129B109F-641D-4176-A35B-BFCCDEE325DE

P1476

Q33912405-60F3B604-4660-4B7A-88DC-C6F46C91B980

P2093

Q33912405-041274C1-464B-41C7-8259-42F304B43D91

Q33912405-12735FF4-D1F9-4534-B222-68FFFDA78309

Q33912405-31113CE2-B4DC-4D12-8D5D-31F4983DF73C

Q33912405-45A085BE-F5C8-450B-A85D-13DD89451158

Q33912405-55EE6B33-2AD8-488A-89BB-C6B54D51A1E7

Q33912405-6229C451-DCE6-41A2-8D9C-8C3DBC398FFE

Q33912405-86D0819A-BC84-4D53-A8FE-4B31BA2E48C5

Q33912405-A5A6E995-C1E5-4F7F-AE66-A6FF7A206485

Q33912405-BAA117E2-B999-4B74-A6ED-D6803ABB2B87

Q33912405-BBD32E55-9BEE-453C-A90A-BF6D32DE7703

P2860

Q33912405-03AACD46-EEB8-4777-8F66-ECAB76F70E20

Q33912405-0D0959EF-71B6-4C3C-BADB-671B96B62012

Q33912405-154F9879-EF20-49A1-91A1-B21A34BE7BBC

Q33912405-170A213E-EE5B-474C-992B-77969A3F5E5C

Q33912405-21DBD28B-13F9-49E2-BEE0-077F822397E7

Q33912405-2E276B36-E778-487A-84AC-7F462E89AB26

Q33912405-4F1D5567-B0C9-47FB-B0DA-494000A2416A

Q33912405-4FE3B437-AF63-4E2B-B89B-40415FF0916D

Q33912405-54E2D1F6-872F-4B19-BE48-28A918EED6AA

Q33912405-5F465B6A-478E-4033-8386-4BD08FF1EDD1

P304

Q33912405-3C4B7884-65F3-47C5-83BD-A4BD552F0EAF

P31

Q33912405-23B3975D-FF5B-4161-B3C9-7A4714E2EC02

P356

Q33912405-68C73F71-F83A-482E-BDE7-885492196918

P433

Q33912405-B440A937-E608-41F2-8C16-A27985B8E6D9

P478

Q33912405-B5974CC7-556A-4775-A455-9B9F5359E2B0

P577

Q33912405-2F8E13C3-CD5A-46A1-9FD1-04064B3A8F71

P5875

Q33912405-87407C8E-507B-44C0-8AD2-7E449103BC90

P698

Q33912405-875FF9D9-EAAC-4A48-8935-645859923014

P932

Q33912405-67955D51-73C1-42CE-B439-E43CD463E2FD

P356

J.TRANON.2014.02.003

P1433

Translational Oncology

P1476

The role of angiopoietins as potential therapeutic targets in renal cell carcinoma.

@en

P2093

Andrea J Bullock

http://www.w3.org/2001/XMLSchema#string

Angela Coxon

http://www.w3.org/2001/XMLSchema#string

David C Alsop

http://www.w3.org/2001/XMLSchema#string

Dongyin Yu

http://www.w3.org/2001/XMLSchema#string

James W Mier

http://www.w3.org/2001/XMLSchema#string

Jon Oliner

http://www.w3.org/2001/XMLSchema#string

Kedar Mahagaokar

http://www.w3.org/2001/XMLSchema#string

Liang Zhang

http://www.w3.org/2001/XMLSchema#string

Lin Wei

http://www.w3.org/2001/XMLSchema#string

Michael B Atkins

http://www.w3.org/2001/XMLSchema#string

P2860

Modes of resistance to anti-angiogenic therapy

Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vessels

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial

Complementary actions of inhibitors of angiopoietin-2 and VEGF on tumor angiogenesis and growth.

Resistance of renal cell carcinoma to sorafenib is mediated by potentially reversible gene expression.

Dynamic contrast-enhanced magnetic resonance imaging of sunitinib-induced vascular changes to schedule chemotherapy in renal cell carcinoma xenograft tumors.

Renal cancer resistance to antiangiogenic therapy is delayed by restoration of angiostatic signaling.

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.

P304

188-195

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.TRANON.2014.02.003

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261407649

http://www.w3.org/2001/XMLSchema#string

P698

24704536

http://www.w3.org/2001/XMLSchema#string

P932

4101387

http://www.w3.org/2001/XMLSchema#string